Literature DB >> 24477683

Regulation of nephron water and electrolyte transport by adenylyl cyclases.

Timo Rieg1, Donald E Kohan.   

Abstract

Adenylyl cyclases (AC) catalyze formation of cAMP, a critical component of G protein-coupled receptor signaling. So far, nine distinct membrane-bound AC isoforms (AC1-9) and one soluble AC (sAC) have been identified and, except for AC8, all of them are expressed in the kidney. While the role of ACs in renal cAMP formation is well established, we are just beginning to understand the function of individual AC isoforms, particularly with regard to hormonal regulation of transporter and channel phosphorylation, membrane abundance, and trafficking. This review focuses on the role of different AC isoforms in regulating renal water and electrolyte transport in health as well as potential pathological implications of disordered AC isoform function. In particular, we focus on modulation of transporter and channel abundance, activity, and phosphorylation, with an emphasis on studies employing genetically modified animals. As will be described, it is now evident that specific AC isoforms can exert unique effects in the kidney that may have important implications in our understanding of normal physiology as well as disease pathogenesis.

Entities:  

Keywords:  homeostasis; parathyroid hormone; renal disease; signaling; vasopressin

Mesh:

Substances:

Year:  2014        PMID: 24477683      PMCID: PMC3962601          DOI: 10.1152/ajprenal.00656.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  89 in total

1.  Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice.

Authors:  Karl P Roos; Kevin A Strait; Kalani L Raphael; Mitsi A Blount; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 2.  cAMP: novel concepts in compartmentalised signalling.

Authors:  Helen V Edwards; Frank Christian; George S Baillie
Journal:  Semin Cell Dev Biol       Date:  2011-09-13       Impact factor: 7.727

Review 3.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

4.  Parathyroid hormone stimulates juxtaglomerular cell cAMP accumulation without stimulating renin release.

Authors:  Douglas K Atchison; Pamela Harding; M Cecilia Ortiz-Capisano; Edward L Peterson; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

Review 5.  New paradigms in cAMP signalling.

Authors:  Ferenc A Antoni
Journal:  Mol Cell Endocrinol       Date:  2011-11-09       Impact factor: 4.102

6.  Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.

Authors:  Eiji Higashihara; Vicente E Torres; Arlene B Chapman; Jared J Grantham; Kyongtae Bae; Terry J Watnick; Shigeo Horie; Kikuo Nutahara; John Ouyang; Holly B Krasa; Frank S Czerwiec
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

7.  Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.

Authors:  Renato O Crajoinas; Felipe T Oricchio; Thaissa D Pessoa; Bruna P M Pacheco; Lucília M A Lessa; Gerhard Malnic; Adriana C C Girardi
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-18

Review 8.  Cell biology of vasopressin-regulated aquaporin-2 trafficking.

Authors:  Hanne B Moeller; Robert A Fenton
Journal:  Pflugers Arch       Date:  2012-06-29       Impact factor: 3.657

9.  Characterization of a novel phosphorylation site in the sodium-chloride cotransporter, NCC.

Authors:  L L Rosenbaek; M Assentoft; N B Pedersen; N MacAulay; R A Fenton
Journal:  J Physiol       Date:  2012-09-10       Impact factor: 5.182

10.  Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.

Authors:  Timo Rieg; Maria Gerasimova; Fiona Murray; Takahiro Masuda; Tong Tang; Michael Rose; Daniel J Drucker; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-25
View more
  12 in total

1.  Renal phosphate wasting in the absence of adenylyl cyclase 6.

Authors:  Robert A Fenton; Fiona Murray; Jessica A Dominguez Rieg; Tong Tang; Moshe Levi; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  Adenylyl cyclase 6 is required for maintaining acid-base homeostasis.

Authors:  Søren Brandt Poulsen; Caralina Marin De Evsikova; Sathish Kumar Murali; Jeppe Praetorius; Yijuang Chern; Robert A Fenton; Timo Rieg
Journal:  Clin Sci (Lond)       Date:  2018-08-30       Impact factor: 6.124

3.  Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Authors:  Esther Meijer; Folkert W Visser; Rene M M van Aerts; Charles J Blijdorp; Niek F Casteleijn; Hedwig M A D'Agnolo; Shosha E I Dekker; Joost P H Drenth; Johan W de Fijter; Maatje D A van Gastel; Tom J Gevers; Marten A Lantinga; Monique Losekoot; A Lianne Messchendorp; Myrte K Neijenhuis; Michelle J Pena; Dorien J M Peters; Mahdi Salih; Darius Soonawala; Edwin M Spithoven; Jack F Wetzels; Robert Zietse; Ron T Gansevoort
Journal:  JAMA       Date:  2018-11-20       Impact factor: 56.272

4.  A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.

Authors:  Murali K Yanda; Qiangni Liu; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2018-06-06       Impact factor: 5.157

5.  Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and Ca2+ Homeostasis.

Authors:  Jose Sanchez-Collado; Jose J Lopez; Isaac Jardin; Gines M Salido; Juan A Rosado
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 6.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 7.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

8.  Regulation of Mg2+ Reabsorption and Transient Receptor Potential Melastatin Type 6 Activity by cAMP Signaling.

Authors:  Maxime G Blanchard; Wararat Kittikulsuth; Anil V Nair; Jeroen H F de Baaij; Femke Latta; Jonathan R Genzen; Donald E Kohan; René J M Bindels; Joost G J Hoenderop
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

9.  STIM1fl/fl Ksp-Cre Mouse has Impaired Renal Water Balance.

Authors:  Liudmila Cebotaru; Valeriu Cebotaru; Hua Wang; Lois J Arend; William B Guggino
Journal:  Cell Physiol Biochem       Date:  2016-06-24

10.  Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease.

Authors:  Murali K Yanda; Qiangni Liu; Valeriu Cebotaru; William B Guggino; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2017-09-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.